Immix Biopharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMMX research report →
About the company
Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases.
- CEO
- Ilya Rachman
- IPO
- 2021
- Employees
- 18
- HQ
- Los Angeles, CA, US
Price Chart
- Market Cap
- $562.52M
- P/E
- -11.24
- P/S
- 0.00
- P/B
- 4.69
- EV/EBITDA
- -14.01
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -73.23%
- ROIC
- -42.25%
- Revenue
- $0 · 0.00%
- Net Income
- $-29,438,613 · -36.21%
- EPS
- $-0.89 · -17.11%
- Op Income
- $-27,211,131
- FCF YoY
- -56.37%
- 52W High
- $11.61
- 52W Low
- $1.94
- 50D MA
- $9.25
- 200D MA
- $6.65
- Beta
- 0.10
- Avg Volume
- 1.39M
Get TickerSpark's AI analysis on IMMX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 26 | Adams Helen C. | other | 6,250 |
| May 22, 26 | Adams Helen C. | other | 12,500 |
| May 22, 26 | Ng Carey | other | 6,250 |
| May 22, 26 | Ng Carey | other | 12,500 |
| May 22, 26 | Marquet Magda | other | 6,250 |
| May 22, 26 | Marquet Magda | other | 12,500 |
| May 22, 26 | Morris Gabriel S | other | 500,000 |
| May 22, 26 | CHANG NANCY T | other | 6,250 |
| May 22, 26 | CHANG NANCY T | other | 12,500 |
| May 22, 26 | Rachman Ilya M | other | 500,000 |
Our IMMX coverage
Recent articles, reports, and earnings notes.
No research on IMMX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMMX report →Similar companies
Peers in the same neighborhood.